Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer

NCT01385293 is registered in ClinicalTrials.gov with Andrew J. Armstrong, MD as lead sponsor.

NCT NCT01385293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01385293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer
Lead sponsor
Andrew J. Armstrong, MD
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2011
Completion date
February 29, 2016
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic (spread to other areas of the body), prostate cancer